FDA's Turmoil Deepens as Vinay Prasad Returns Amid Dissent
The article advises Vinay, upon his return to the FDA, to embrace dissent, listen more, and focus on leading through the agency rather than seeking personal prominence, emphasizing the importance of making the FDA's work the center of attention.